The Vanderbilt Institute for Clinical and Translational Research (VICTR)

蒂伊·范德比尔特临床与翻译研究所(VICTR)已成立，是一个充满活力的 以及培育临床和转化科学的家园。在四年时间里，卢旺达问题国际法庭牢牢地融入了 进入Vanderbilt，Meharry联合体，为加强临床和翻译研究提供重点 所有学科，并创建、组织和提供可用的临床和翻译科学工具、方法、 资源和教育项目。我们精简了行政程序，推动了 CTSA的翻译精神。所追求的创新和改进使研究和 研究人员蓬勃发展：去年有600多名调查人员得到卢旺达问题国际法庭的支持。通过支持 CTSA，所提供的服务得到了扩展，使用更频繁，并已被使用 整个财团。范德比尔特内部的所有相关学科都可以访问这些服务 Meharry和研究人员在他们职业生涯的每个阶段。我们的续期建议的具体目的是： 1)系统地消除翻译研究的障碍；2)创作并提供小说， 支持研究的基础设施和资源；3)培训下一代调查人员；4)参与和 让当地社区参与；以及5)确定并持续衡量在实现目标方面的成功。 为国家CTSA联合体作出贡献是卢旺达问题国际法庭的一个目标，因为整个方案是成功的 对于它的连续性和对推动临床和翻译的真正社会影响来说，都是必不可少的 科学。我们将继续以多种方式作出贡献，包括积极参与委员会和 在领导班子内，分享新方法，并继续发展和传播 软件和工具。在下一个赠款周期中，卢旺达问题国际法庭小组将继续推动发现和想法。 毫不拖延地通过研究的光谱有效地将其转化为临床实践。 相关性(见说明)：范德比尔特临床和翻译研究所专注于移除 研究翻译、创建新的基础设施、培训新的C&T科学家以及参与的障碍 并让当地社区参与进来，以改善健康。卢旺达问题国际法庭向CJTSA财团作出贡献，包括 软件和工具的开发和传播。在下一个赠款周期中，卢旺达问题国际法庭将继续 毫不拖延地推动研究领域的发现和想法，以有效地翻译成 临床实践。

Tiie Vanderbilt Institute for Clinical and Translational Research (VICTR) has been established as a vibrant and nurturing home for clinical and translational science. In four years, VICTR has become firmly integrated into the Vanderbilt, Meharry Consortium providing a,focus for enhanced clinical and translational research for all disciplines and creating, organizing and making available clinical and translational science tools, methods, resources and educational programs. We have streamlined administrative processes and promoted the translational spirit ofthe CTSA. The innovations and improvements pursued have enabled both research and researchers to thrive: over 600 investigators were supported by VICTR last year. Through the support of the CTSA, the services offered have been expanded, have been used more frequently and have been used across the consortium. These services have been accessed by all relevant disciplines within Vanderbilt and Meharry and by researchers at every stage of their career. The specific aims of our renewal proposal are to: 1) Systematically remove impediments to research translation; 2) Create and make available novel, research-enabling infrastructure and resources; 3) Train the next generation of investigators; 4) Engage and involve the local community; and 5) Define and continuously measure success in meeting objectives. Contributing to the national CTSA consortium is an objective of VICTR, as the success of the entire program is essential both for its continuity, and for the real societal impact on propelling clinical and translational science. We will continue to contribute in a number of ways, including active service on committees and within the leadership group, sharing of novel methods, and continued development and dissemination of software and tools. In the next grant cycle the VICTR team will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice. RELEVANCE (See instructions): Vanderbilt Institute for Clinical and Translational Research is focused on removing impediments to research translation, creating new infrastructure, training new C&T scientists, and engaging and involving the local community to improve health. VICTR contributes to the CJTSA consortium, including the development and dissemination of software and tools. In the next grant cycle VICTR will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice.